These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 16552058

  • 1. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S, Kamanova J, Simsova M, Sebo P, Bolte S, Heussler V, Fleischer B, Jacobs T.
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [Abstract] [Full Text] [Related]

  • 2. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S, Rüssmann H, Kamanova J, Sebo P, Sturm A, Heussler V, Fleischer B, Jacobs T.
    Vaccine; 2008 Nov 05; 26(47):5935-43. PubMed ID: 18804138
    [Abstract] [Full Text] [Related]

  • 3. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V, Romero JF, Kensil C, Corradin G.
    Vaccine; 2005 Apr 15; 23(21):2801-12. PubMed ID: 15780728
    [Abstract] [Full Text] [Related]

  • 4. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL, Snyder HL, Krzych U.
    J Immunol; 1996 May 01; 156(9):3374-81. PubMed ID: 8617963
    [Abstract] [Full Text] [Related]

  • 5. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouzé C, Ladant D, Cole ST, Sebo P, Leclerc C.
    Infect Immun; 2006 Apr 01; 74(4):2128-37. PubMed ID: 16552042
    [Abstract] [Full Text] [Related]

  • 6. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C, Bauche C, Ladant D, Leclerc C.
    Vaccine; 2004 Dec 16; 23(5):604-14. PubMed ID: 15542180
    [Abstract] [Full Text] [Related]

  • 7. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, Gao G, Ertl HC, Wilson JC, Hill AV.
    Eur J Immunol; 2008 Mar 16; 38(3):732-41. PubMed ID: 18266272
    [Abstract] [Full Text] [Related]

  • 8. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R.
    J Immunol; 2009 Nov 01; 183(9):5870-8. PubMed ID: 19812194
    [Abstract] [Full Text] [Related]

  • 9. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
    Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C.
    J Immunol; 1996 Jun 15; 156(12):4697-706. PubMed ID: 8648115
    [Abstract] [Full Text] [Related]

  • 10. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
    Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C.
    J Immunol; 1999 Apr 01; 162(7):4157-62. PubMed ID: 10201941
    [Abstract] [Full Text] [Related]

  • 11. Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection.
    Gibbins MP, Müller K, Glover M, Liu J, Putrianti ED, Bauza K, Reyes-Sandoval A, Matuschewski K, Silvie O, Hafalla JCR.
    Infect Immun; 2020 Sep 18; 88(10):. PubMed ID: 32719159
    [Abstract] [Full Text] [Related]

  • 12. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.
    Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F.
    Nature; 1989 Sep 28; 341(6240):323-6. PubMed ID: 2477703
    [Abstract] [Full Text] [Related]

  • 13. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF, Ibrahim GH, Renggli J, Himmelrich H, Graber P, Corradin G.
    Parasite Immunol; 2007 Nov 28; 29(11):541-8. PubMed ID: 17944743
    [Abstract] [Full Text] [Related]

  • 14. Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8(+) memory T cells.
    Tartz S, Deschermeier C, Retzlaff S, Heussler V, Sebo P, Fleischer B, Jacobs T.
    Eur J Immunol; 2013 Mar 28; 43(3):693-704. PubMed ID: 23229763
    [Abstract] [Full Text] [Related]

  • 15. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei.
    Bergmann-Leitner ES, Duncan EH, Leitner WW, Neutzner A, Savranskaya T, Angov E, Tsokos GC.
    Vaccine; 2007 Nov 07; 25(45):7732-6. PubMed ID: 17931754
    [Abstract] [Full Text] [Related]

  • 16. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL, Hoffman SL.
    J Immunol; 1999 Jul 15; 163(2):884-92. PubMed ID: 10395683
    [Abstract] [Full Text] [Related]

  • 17. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C, Doolan DL.
    Mol Immunol; 2007 Apr 15; 44(11):3037-48. PubMed ID: 17303242
    [Abstract] [Full Text] [Related]

  • 18. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
    Simsova M, Sebo P, Leclerc C.
    Int J Med Microbiol; 2004 Apr 15; 293(7-8):571-6. PubMed ID: 15149033
    [Abstract] [Full Text] [Related]

  • 19. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 20. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.
    J Virol; 2005 Aug 15; 79(15):9872-84. PubMed ID: 16014948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.